Evidence map›Paper›PMID 42290566›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2026

Congenital cytomegalovirus infection drives oligoclonal expansion of cytotoxic γδ T cells from early fetal progenitors.

Justine Levan, Anna V Vaaben, Jessica Tsui, Brittany R Davidson, Meagan E Olive, Perri C Callaway, Catherine B T Nguyen, Mikias Ilala, Ravi K Patel, Riana D Hunter and 7 more

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Justine LevanDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0002-3185-6069
Anna V VaabenDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States.ORCID 0009-0008-3057-0238
Jessica TsuiUCSF CoLabs, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0002-1336-6760
Brittany R DavidsonUCSF CoLabs, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0003-3538-2822
Meagan E OliveDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0001-8287-9474
Perri C CallawayDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0002-5135-0698
Catherine B T NguyenDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Mikias IlalaDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States.ORCID 0009-0003-1735-522X
Ravi K PatelUCSF CoLabs, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0001-5203-899X
Riana D HunterDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0002-2888-1079
Gabriela K FragiadakisUCSF CoLabs, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0001-9703-2591
Alexis J CombesUCSF CoLabs, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0002-9110-6542
Felistas NankyaInfectious Diseases Research Collaboration, Kampala, Uganda.ORCID 0009-0004-6011-9801
Grant DorseyDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0003-0740-0317
Abel KakuruInfectious Diseases Research Collaboration, Kampala, Uganda.ORCID 0000-0001-9941-1309
Mary MuhindoInfectious Diseases Research Collaboration, Kampala, Uganda.ORCID 0000-0002-5328-0523
Margaret E FeeneyDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0002-2515-2989

Funding

The immunologic consequences of prenatal exposure to malariaP01HD059454 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHARLEBOIS, EDWIN DUNCAN · 2008 to 2017
$22.6M
T cell immunity to CMV in utero and in early childhoodU01AI168390 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARGARET E FEENEY · 2022 to 2026
$3.9M
Mentoring Translational Researchers for Careers in Pediatric Global HealthK24AI113002 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FEENEY, MARGARET E · 2014 to 2023
$1.9M
Illumina NovaSeq 6000 Sequencing SystemS10OD028511 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHOW, ERIC D · 2020 to 2020
$583k
BD FACSAria Fusion Cell SorterS10OD021822 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEE, MICHAEL R. · 2016 to 2016
$573k
American Association of Immunologists Intersect FellowshipNIAID NIH HHS K24 AI113002NIAID NIH HHS U01 AI168390NICHD NIH HHS P01 HD059454NIH HHS K24AI113002NIH HHS P01HD059454NIH HHS S10 OD021822NIH HHS S10 OD028511NIH HHS U01AI168390
6 · The paper itself

Abstract

Gamma delta (γδ) T cells emerge early during human gestation and are uniquely equipped to protect the fetus and infant following infection, due to their innate-like recognition of conserved molecular ligands. Following congenital cytomegalovirus infection (cCMV), Vδ1 T cells have been shown to expand, differentiate, and upregulate cytotoxic mediators, but display markedly restricted γδTCR diversity compared to CMV-infected adults. Early fetal γδ T cells are biased toward rapid effector function and comprise a distinct ontological "layer" that can be distinguished from late gestation γδ T cells based on TCR characteristics. To better understand the contribution of fetal γδ T cells to antiviral defense in utero, we analyzed γδ T cells from cCMV+ and uninfected neonates in Uganda using flow cytometry and paired single-cell RNA and TCR sequencing. We observed that in cCMV+ neonates, γδ T cells clonally proliferate and differentiate into a uniform population of cytotoxic effectors. The expanded Vδ1 population is comprised of diverse clonotypes with broad Vγ chain usage, with a striking correlation between expansion and publicity. Overall, γδTCR repertoires of cCMV+ infants have shorter CDR3 lengths and fewer N additions, suggesting they derive from early fetal progenitor cells. In cCMV+ infants, most cells with fetal γδTCR characteristics are effector-differentiated, whereas in uninfected infants, such cells are rare and predominantly naïve. Together, these findings demonstrate that cCMV infection drives an oligoclonal expansion of highly cytotoxic effector γδ T cells with fetal-like TCR features, illustrating how the developing immune system prioritizes broad reactivity and rapid effector function over specificity.

Indexed as

CytomegalovirusCytomegalovirus InfectionsReceptors, Antigen, T-Cell, gamma-deltaT-Lymphocytes, CytotoxicFemaleHumansInfant, NewbornPregnancyReceptors, Antigen, T-Cell, gamma-deltacongenital CMVearly life immunitygamma delta T cells

Identifiers

PMID42290566
PMCPMC13266404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.